Price T Rowe Associates Inc. MD Has $1 Million Stock Holdings in Delek US Holdings, Inc. (NYSE:DK)

Price T Rowe Associates Inc. MD boosted its position in shares of Delek US Holdings, Inc. (NYSE:DK) by 21.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 54,042 shares of the oil and gas company’s stock after purchasing an additional 9,600 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.09% of Delek US worth $1,000,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Sterling Capital Management LLC grew its position in shares of Delek US by 728.3% in the 4th quarter. Sterling Capital Management LLC now owns 1,491 shares of the oil and gas company’s stock valued at $28,000 after purchasing an additional 1,311 shares during the period. KBC Group NV raised its holdings in shares of Delek US by 66.3% during the fourth quarter. KBC Group NV now owns 3,859 shares of the oil and gas company’s stock worth $71,000 after acquiring an additional 1,538 shares during the period. ARS Investment Partners LLC bought a new stake in Delek US in the 4th quarter valued at $185,000. Abel Hall LLC acquired a new position in Delek US in the 4th quarter worth $196,000. Finally, Diametric Capital LP bought a new position in Delek US during the 4th quarter worth about $251,000. Institutional investors own 97.01% of the company’s stock.

Delek US Stock Performance

Shares of NYSE DK opened at $15.34 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 3.18. The company has a market capitalization of $958.95 million, a P/E ratio of -3.16 and a beta of 0.74. Delek US Holdings, Inc. has a 12 month low of $11.03 and a 12 month high of $28.91. The stock has a 50 day moving average of $14.10 and a 200-day moving average of $16.61.

Delek US (NYSE:DK) last released its quarterly earnings data on Wednesday, May 7th. The oil and gas company reported ($2.32) EPS for the quarter, missing the consensus estimate of ($2.27) by ($0.05). The company had revenue of $2.64 billion during the quarter, compared to analyst estimates of $2.56 billion. Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. Delek US’s revenue for the quarter was down 18.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.41) earnings per share. As a group, equities research analysts predict that Delek US Holdings, Inc. will post -5.5 EPS for the current year.

Delek US Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 19th. Stockholders of record on Monday, May 12th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 6.65%. The ex-dividend date of this dividend is Monday, May 12th. Delek US’s dividend payout ratio is presently -11.54%.

Insider Activity

In other Delek US news, CFO Mark Wayne Hobbs purchased 2,800 shares of the firm’s stock in a transaction that occurred on Tuesday, March 11th. The shares were acquired at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the completion of the purchase, the chief financial officer now owns 49,138 shares of the company’s stock, valued at approximately $673,190.60. The trade was a 6.04 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders have bought 5,055 shares of company stock valued at $70,787. 1.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

DK has been the subject of several recent research reports. Morgan Stanley reduced their price objective on Delek US from $18.00 to $14.00 and set an “underweight” rating for the company in a research report on Thursday, April 24th. Wells Fargo & Company decreased their price target on shares of Delek US from $16.00 to $11.00 and set an “underweight” rating for the company in a research note on Wednesday, April 16th. Piper Sandler cut their price objective on shares of Delek US from $18.00 to $17.00 and set a “neutral” rating on the stock in a research report on Friday, March 7th. Scotiabank lowered their price target on shares of Delek US from $24.00 to $14.00 and set a “sector perform” rating on the stock in a research note on Friday, April 11th. Finally, Mizuho reduced their price objective on shares of Delek US from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 9th. Five equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $16.94.

About Delek US

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.